Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Balthasar

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Cancers|May 14, 2025
Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab ImmunotoxinPing Chen, Yu Zhang, Brandon M Bordeau, et al.
The AAPS Journal|May 9, 2025
Investigations of Influence of Antibody Binding Kinetics on Tumor Distribution and Anti-Tumor EfficacyPing Chen, Brandon M Bordeau, Wenqiu Zhang, et al.
Molecular Cancer Therapeutics|August 5, 2022
Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin ImmunotoxinPing Chen, Brandon M Bordeau, Yu Zhang, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2011
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancerDhaval K Shah, Jean Veith, Ralph J Bernacki, et al.
The AAPS Journal|March 26, 2022
Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer EfficacyJoseph Ryan Polli, Ping Chen, Brandon M Bordeau, et al.
Analytical Chemistry|April 24, 2012
High-throughput method development for sensitive, accurate, and reproducible quantification of therapeutic monoclonal antibodies in tissues using orthogonal array optimization and nano liquid chromatography/selected reaction monitoring mass spectrometryXiaotao Duan, Lubna Abuqayyas, Lipeng Dai, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 28, 2009
Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissuesShweta R Urva, Beom Soo Shin, Victor C Yang, et al.
Journal of Chromatography. A|July 10, 2012
Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysisXiaotao Duan, Lipeng Dai, Shang-Chiung Chen, et al.
Nature Reviews. Cancer|October 2, 2025
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatmentAlfred Zippelius, Sara M Tolaney, Paolo Tarantino, et al.
Frontiers in Pharmacology|March 7, 2022
Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site BarrierBrandon M Bordeau, Lubna Abuqayyas, Toan D Nguyen, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancers|May 14, 2025
Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab ImmunotoxinPing Chen, Yu Zhang, Brandon M Bordeau, et al.
The AAPS Journal|May 9, 2025
Investigations of Influence of Antibody Binding Kinetics on Tumor Distribution and Anti-Tumor EfficacyPing Chen, Brandon M Bordeau, Wenqiu Zhang, et al.
Molecular Cancer Therapeutics|August 5, 2022
Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin ImmunotoxinPing Chen, Brandon M Bordeau, Yu Zhang, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2011
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancerDhaval K Shah, Jean Veith, Ralph J Bernacki, et al.
The AAPS Journal|March 26, 2022
Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer EfficacyJoseph Ryan Polli, Ping Chen, Brandon M Bordeau, et al.
Analytical Chemistry|April 24, 2012
High-throughput method development for sensitive, accurate, and reproducible quantification of therapeutic monoclonal antibodies in tissues using orthogonal array optimization and nano liquid chromatography/selected reaction monitoring mass spectrometryXiaotao Duan, Lubna Abuqayyas, Lipeng Dai, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 28, 2009
Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissuesShweta R Urva, Beom Soo Shin, Victor C Yang, et al.
Journal of Chromatography. A|July 10, 2012
Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysisXiaotao Duan, Lipeng Dai, Shang-Chiung Chen, et al.
Nature Reviews. Cancer|October 2, 2025
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatmentAlfred Zippelius, Sara M Tolaney, Paolo Tarantino, et al.
Frontiers in Pharmacology|March 7, 2022
Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site BarrierBrandon M Bordeau, Lubna Abuqayyas, Toan D Nguyen, et al.
Pageof 9